​

Oculis (OCS) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChart

OCS Stock Forecast

Oculis (OCS) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $33.50, with a high of $37.00 and a low of $30.00. This represents a 51.24% increase from the last price of $22.15.

$10 $16 $22 $28 $34 $40 High: $37 Avg: $33.5 Low: $30 Last Closed Price: $22.15

OCS Stock Rating

Oculis stock's rating consensus is Buy, based on 2 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 2 0 2 Strong Sell Sell Hold Buy Strong Buy

OCS Forecast vs Benchmarks

TypeNameUpside
StockOculis51.24%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$33.50
Last Closing Price$22.15$22.15$22.15
Upside/Downside--51.24%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2525---7
Dec, 2425---7
Nov, 2455---10
Oct, 2455---10
Sep, 2465---11
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 11, 2024Yi ChenH.C. Wainwright$30.00$12.00150.00%35.44%
Jun 10, 2024Colleen KusyRobert W. Baird$37.00$12.00208.33%67.04%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 29, 2024Sandler O'NeillUnderperformUnderperformhold
Sep 24, 2024Sandler O'NeillUnderperformUnderperformhold
Aug 28, 2024H.C. WainwrightBuyBuyhold
Aug 21, 2024Sandler O'NeillUnderperformUnderperformhold
Jul 15, 2024Sandler O'NeillUnderperformUnderperformhold
Jun 21, 2024Sandler O'NeillUnderperformUnderperformhold
Jun 11, 2024H.C. WainwrightBuyBuyhold
Jun 11, 2024Bank of America SecuritiesBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.97-----
Avg Forecast$-3.07$-1.86$-1.86$-2.37$-1.77$-0.91
High Forecast$-4.07$-1.96$-2.47$-4.50$-3.06$-4.35
Low Forecast$-1.68$-1.61$-1.20$0.22$0.11$0.17
Surprise %-3.26%-----

Revenue Forecast

$0 $170M $340M $510M $680M $850M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$883.00K-----
Avg Forecast$901.80K$903.13K$6.99M$15.38M$85.45M$211.74M
High Forecast$787.98K$803.78K$568.78K$1.31M$7.27M$18.02M
Low Forecast$998.11K$930.22K$26.20M$60.26M$334.90M$829.87M
Surprise %-2.09%-----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-88.80M-----
Avg Forecast$-75.96M$-58.52M$-65.28M$-76.01M$-44.10M$-27.13M
High Forecast$-121.55M$-58.57M$-73.97M$-134.57M$-91.59M$-130.08M
Low Forecast$-50.15M$-48.19M$-35.90M$6.52M$3.39M$5.14M
Surprise %16.90%-----

OCS Forecast FAQ

Is Oculis stock a buy?

Oculis stock has a consensus rating of Buy, based on 2 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Oculis is a favorable investment for most analysts.

What is Oculis's price target?

Oculis's price target, set by 2 Wall Street analysts, averages $33.5 over the next 12 months. The price target range spans from $30 at the low end to $37 at the high end, suggesting a potential 51.24% change from the previous close price of $22.15.

How does Oculis stock forecast compare to the average forecast of its sector, industry, and investment themes?

Oculis stock forecast shows a 51.24% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Oculis over the past three months?

  • January 2025: 28.57% Strong Buy, 71.43% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 28.57% Strong Buy, 71.43% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Oculis’s EPS forecast?

Oculis's average annual EPS forecast for its fiscal year ending in December is -1.86 for 2024, a -37.37% decrease from the reported $-2.97 in 2023. The prediction for 2025 is $-1.86, $-2.37 for 2026, $-1.77 for 2027, and $-0.91 for 2028.

What is Oculis’s revenue forecast?

Oculis's average annual revenue forecast for its fiscal year ending in December is $903.13K for 2024, a 2.28% increase from the reported $883K in 2023. The forecast for 2025 is $6.99M, $15.38M for 2026, $85.45M for 2027, and $211.74M for 2028.

What is Oculis’s net income forecast?

For its fiscal year ending in December, Oculis's average annual net income forecast is $-58.516M for 2024, reflecting a -34.10% decrease from the reported $-88.802M in 2023. The projection for 2025 is $-65.281M, $-76.007M for 2026, $-44.104M for 2027, and $-27.129M for 2028.